Evaluation of the international index in the prognosis of high grade gastric MALT lymphoma

被引:12
作者
Castrillo, JM
Montalban, C
Abraira, V
Carrion, R
Cruz, MA
Larana, JG
Menarguez, J
Bellas, C
Piris, MA
GomezMarcos, F
Serrano, M
Rivas, C
机构
[1] Department of Internal Medicine, Fondación Jimenez Díaz, Universidad Autónoma, Madrid
[2] Department of Pathology, Fondación Jimenez Díaz, Universidad Autónoma, Madrid
[3] Department of Internal Medicine, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[4] Department of Oncology, Hospital Gregorio Marañon, Universidad Complutense, Madrid
[5] Department of Pathology, Hospital Gregorio Marañon, Universidad Complutense, Madrid
[6] Department of Hematology, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[7] Department of Oncology, Hospital Virgen de la Salud, Toledo
[8] Department of Pathology, Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[9] Clin. Epidemiol. and Biostatist. U., Hospital Ramón y Cajal, Univ. de Alcalá de Henares, Madrid
[10] Servicio de Medicina Interna, Fundación Jimenez Díaz, Madrid 28040
关键词
gastric lymphoma; high-grade lymphoma; international index; lymphoma; MALT lymphoma;
D O I
10.3109/10428199609045724
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The International Prognostic Index identifies four risk groups with different survival rates in aggressive non-Hodgkin's lymphoma. We have studied whether a slight modification of this index has prognostic significance in high grade gastric B-cell MALT lymphoma. In 53 patients with high grade gastric B-cell MALT lymphoma the following survival factors were investigated: age over or under 60 years, sex, B symptoms, more than one extranodal site of involvement other than the stomach, serum LDH levels, performance status, stage I/IIE1/IIE2 v.s. stage III/IV, treatment with surgery, chemotherapy or both modalities together and the four risk groups as defined by the Modified International Prognostic Index (MIPI). A multivariate Cox's test was used to evaluate the independent prognostic significance on survival of all the above variables. Advanced stage (III/IV) and involvement of more than one extranodal site not including stomach were the only variables influencing survival. The MIPI was not sufficient to separate groups with significant differences in survival or to stratify prognostic groups. In this series, the MIPI did not show prognostic significance in high grade gastric B-cell MALT lymphoma.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [41] Primary low-grade MALT lymphoma of the gallbladder
    Tsuchiya, T
    Shimokawa, I
    Higami, Y
    Ohtani, H
    Shigeoka, Y
    Ohshima, K
    Tanaka, K
    Ayabe, H
    PATHOLOGY INTERNATIONAL, 2001, 51 (12) : 965 - 969
  • [42] Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy
    Ueda, Kyoko
    Terui, Yasuhito
    Yokoyama, Masahiro
    Sakajiri, Sakura
    Nishimura, Noriko
    Tsuyama, Naoko
    Takeuchi, Kengo
    Hatake, Kiyohiko
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1928 - 1933
  • [43] Gastric MALT-type lymphoma: Pathology, pathogenesis, diagnostics and therapy
    Eck M.
    Fischbach W.
    Der Pathologe, 2010, 31 (3): : 188 - 194
  • [44] Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies
    Montalban, C
    Manzanal, A
    Boixeda, D
    Redondo, C
    Alvarez, I
    Calleja, JL
    Bellas, C
    ANNALS OF ONCOLOGY, 1997, 8 : 37 - 39
  • [45] Treatment and prognosis of gastric lymphoma
    Brands, F
    Monig, SP
    Raab, M
    EUROPEAN JOURNAL OF SURGERY, 1997, 163 (11) : 803 - 813
  • [46] Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study
    Capelle, L. G.
    de Vries, A. C.
    Looman, C. W. N.
    Casparie, M. K.
    Boot, H.
    Meijer, G. A.
    Kuipers, E. J.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) : 2470 - 2476
  • [47] GASTRIC B-CELL MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) LYMPHOMA - CLINICOPATHOLOGICAL STUDY AND EVALUATION OF THE PROGNOSTIC FACTORS IN 143 PATIENTS
    MONTALBAN, C
    CASTRILLO, JM
    ABRAIRA, V
    SERRANO, M
    BELLAS, C
    PIRIS, MA
    CARRION, R
    CRUZ, MA
    LARANA, JG
    MENARGUEZ, J
    GOMEZMARCOS, F
    RIVAS, C
    ANNALS OF ONCOLOGY, 1995, 6 (04) : 355 - 362
  • [48] Rituximab-induced remission of a gastric MALT lymphoma
    Datta, YH
    Kampalath, B
    Binion, DG
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1297 - 1299
  • [49] Can we eradicate gastric MALT-lymphoma?
    Zullo, Angelo
    Hassan, Cesare
    Cristofari, Francesca
    Legri, Claudia
    Villiva, Nicoletta
    Andriani, Alessandro
    Morini, Sergio
    ITALIAN JOURNAL OF MEDICINE, 2010, 4 (03) : 154 - 158
  • [50] Gastric perforation by MALT lymphoma. Case report
    Lopez-Zamudio, Jose
    Ricardo Ramirez-Gonzalez, Luis
    Nunez-Marquez, Julia
    Fuentes Orozco, Clotilde
    Gonzalez Ojeda, Alejandro
    Lisseth Leonher-Ruezga, Karla
    CIRUGIA Y CIRUJANOS, 2015, 83 (03): : 217 - 221